There have been some wonderful advances in cancer therapy, such as immunotherapy. For example, Rituxan (rituximab) only dates to 1997, but it's already in a num

There have been some wonderful advances in cancer therapy, such as immunotherapy. For example, Rituxan (rituximab) only dates to 1997, but it's already in a number of chemotherapy protocols, leading to a clear improvement in survival rates in previously difficult-to-treat cancers such as aggressive non-Hodgkin's lymphoma. https://en.wikipedia.org/wiki/Rituximab https://en.wikipedia.org/wiki/Rituximab https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398399/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398399/ Flashier, and something I've already talked about, is CAR T-cell therapy, the first generations of which were approved in 2017. This therapy has definite risks of severe side-effects, but it can result in complete remission of cancers that have survived multiple lines of chemotherapy, as happened with me. https://en.wikipedia.org/wiki/CAR_T_cell https://en.wikipedia.org/wiki/CAR_T_cell Immunotherapy isn't just promising, it's here, and, because of it, so am I, but even more exciting is that it gives us more avenues of research to build off of known-useful therapies.